JPS5058213A - - Google Patents

Info

Publication number
JPS5058213A
JPS5058213A JP48107613A JP10761373A JPS5058213A JP S5058213 A JPS5058213 A JP S5058213A JP 48107613 A JP48107613 A JP 48107613A JP 10761373 A JP10761373 A JP 10761373A JP S5058213 A JPS5058213 A JP S5058213A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP48107613A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP48107613A priority Critical patent/JPS5058213A/ja
Priority to GB3366774A priority patent/GB1474424A/en
Priority to AU72265/74A priority patent/AU460520B2/en
Priority to DE2445801A priority patent/DE2445801C2/de
Priority to US509604A priority patent/US3929995A/en
Priority to FR7432479A priority patent/FR2244487B1/fr
Publication of JPS5058213A publication Critical patent/JPS5058213A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP48107613A 1973-09-26 1973-09-26 Pending JPS5058213A (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP48107613A JPS5058213A (sv) 1973-09-26 1973-09-26
GB3366774A GB1474424A (en) 1973-09-26 1974-07-30 Pharmaceutical composition for treating diabetic ketoacidosis
AU72265/74A AU460520B2 (en) 1973-09-26 1974-08-13 Method for treating diabetic ketoacidosis
DE2445801A DE2445801C2 (de) 1973-09-26 1974-09-25 Parenteral oder oral verabreichbares Arzneimittel zur Behandlung von diabetischer Ketoacidose
US509604A US3929995A (en) 1973-09-26 1974-09-26 Method for treating diabetic ketoacidosis
FR7432479A FR2244487B1 (sv) 1973-09-26 1974-09-26

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP48107613A JPS5058213A (sv) 1973-09-26 1973-09-26

Publications (1)

Publication Number Publication Date
JPS5058213A true JPS5058213A (sv) 1975-05-21

Family

ID=14463599

Family Applications (1)

Application Number Title Priority Date Filing Date
JP48107613A Pending JPS5058213A (sv) 1973-09-26 1973-09-26

Country Status (5)

Country Link
US (1) US3929995A (sv)
JP (1) JPS5058213A (sv)
DE (1) DE2445801C2 (sv)
FR (1) FR2244487B1 (sv)
GB (1) GB1474424A (sv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60239427A (ja) * 1984-05-02 1985-11-28 メルク　エンド　カムパニー　インコーポレーテッド アシルカルニチンを用いる胃腸からの医薬吸収を増大させる方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1143611B (it) * 1977-11-03 1986-10-22 Sigma Tau Ind Farmaceuti Applicazione della acetil-carnitina nella terapia delle affezioni cardiache di/tipo anossico,ischemico,cardiotossico e nelle sindromi aritmiche
IT1156741B (it) * 1978-05-15 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi
IT1206954B (it) * 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti Agenti terapeutici a base di un acil derivato della carnitina per la cura di vasculopatie periferiche
IT1116037B (it) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
IT1133010B (it) * 1980-05-15 1986-07-09 Sigma Tau Ind Farmaceuti Metodo terapuetico per il trattamento del diabete mellito a insorgenza giovanile e composizione farmaceutica per tale metodo
US4731360A (en) * 1985-08-16 1988-03-15 Merck & Co., Inc. Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments
IT1231944B (it) * 1989-05-05 1992-01-16 Sigma Tau Ind Farmaceuti Composizione farmaceutica per il trattamento di protozoosi, particolarmente della tripasonomiasi comprendente d-carnitina o un alcanoilderivato della d-carnitina
US10799564B1 (en) 2019-05-06 2020-10-13 Baxter International Inc. Insulin premix formulation and product, methods of preparing same, and methods of using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624887A (en) * 1970-03-02 1971-12-07 Bunker Ramo Pin and socket removal tool

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60239427A (ja) * 1984-05-02 1985-11-28 メルク　エンド　カムパニー　インコーポレーテッド アシルカルニチンを用いる胃腸からの医薬吸収を増大させる方法

Also Published As

Publication number Publication date
GB1474424A (en) 1977-05-25
DE2445801C2 (de) 1985-05-09
FR2244487B1 (sv) 1978-06-30
AU7226574A (en) 1975-05-01
DE2445801A1 (de) 1975-04-03
FR2244487A1 (sv) 1975-04-18
US3929995A (en) 1975-12-30

Similar Documents

Publication Publication Date Title
AR201758A1 (sv)
AU476761B2 (sv)
AU465372B2 (sv)
AR201235Q (sv)
AR201231Q (sv)
AU474593B2 (sv)
AU474511B2 (sv)
AU474838B2 (sv)
AU471343B2 (sv)
AU465453B2 (sv)
AU465434B2 (sv)
AU450229B2 (sv)
AU476714B2 (sv)
FR2244487B1 (sv)
AR201229Q (sv)
AU472848B2 (sv)
AU476696B2 (sv)
AR199451A1 (sv)
AU477823B2 (sv)
AR210729A1 (sv)
AR201432A1 (sv)
AR200256A1 (sv)
AR200885A1 (sv)
AU477824B2 (sv)
AU476873B1 (sv)